Novartis AG Common Stock (NVS)
R&D Expense Growth
0.69%
Quarterly · Period ending:
NVS R&D Expense Growth
Latest reported0.69%period ending
Latest reported0.69%period ending
NVS Quarterly R&D Growth (QoQ) (0.00% → 0.69%)
Latest values, visible window
High-resolution chart · PNG
NVS r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% |